Ballicules.com

Thiothixene

NAVANE

What it isD2-predominant thioxanthene antipsychotic; schizophrenia.

Why this oneIts niche is an inexpensive oral typical with less sedation and antimuscarinic toxicity than low-potency agents, but no depot form.

What limits itAkathisia, parkinsonism, and tardive dyskinesia commonly limit use; QT prolongation and NMS remain serious risks.

FDA-approved for

FDA label

BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis treated with antipsychotics; not approved for dementia-related psychosis.
FDA dosingPopulationStartTargetMax
Schizophrenia (milder)Adults2 mg TID15 mg/day60 mg/day
Schizophrenia (more severe)Adults5 mg BID20-30 mg/day60 mg/day

Renal Undefined

Hepatic Undefined

Exceeding 60 mg/day rarely increases benefit

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

⚠ BOXED WARNING

Cost, est. cash$10–$300/month

Generic entry1987

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability1 / 4
Sedation liability1 / 4
QT / Torsades1 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityMetabolic effects, extrapyramidal symptoms/tardive dyskinesia and agent-specific QT or orthostatic risk.

Mechanism of action: Thiothixene ballicule

Thiothixene ballicule: receptor binding, kinetics and half-life diagram

Open Thiothixene in the interactive console ↗

Memory aids: mascots and interaction avatars

Thiothixene NAVANE mascot mnemonic cartoon
“Thighs thick to Navel”
spooky mascot in greyscale → high potency first-gen antipsychotic
Thiothixene CYP1A2 substrate avatar
CYP1A2 substrate

Open Thiothixene in the interactive console ↗